Calls Now Open
2027 Scholar-Innovator and ADDF-Harrington
May 20, 2026
[image:1] A former British prime minister, a Cleveland sports owner, and a race to cure diseases that have stumped science Former British PM David Cameron brings his personal mission to Cleveland as a major rare disease conference begins at the Cleveland Museum of Natural History. CLEVELAND — When Lord David Cameron...
Continue Reading
May 19, 2026
New study of human cancers published in Science Signaling Continue Reading
May 12, 2026
Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic Continue Reading
May 06, 2026
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center Continue Reading
April 21, 2026
Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading
March 24, 2026
2026 Harrington Prize for Innovation in Medicine recognizes pioneering work in prostate cancer diagnosis and treatment Continue Reading
March 10, 2026
The annual Cozzarelli Prize acknowledges papers that reflect scientific excellence and originality. Continue Reading
January 15, 2026
Prestigious Scholar Award Accelerates Novel Therapies for Patients with Rare Diseases Continue Reading
December 23, 2025
New Study from University Hospitals and Case Western Reserve University published in Science Signaling Continue Reading
December 22, 2025
For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease prevention or slowing, rather than recovery. Despite billions of dollars spent on decades of research, there has never been a clinical trial of a drug for AD with an outcome goal of reversing disease and... Continue Reading
November 20, 2025
Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat rare and ultra-rare diseases Continue Reading